Desq Long
Sign in
SEC FORM 4
$0.00

Actinium Pharmaceuticals, Inc. (ATNM)

Acquisition (code A) of 250,000 shares at $0 per share.

Reporting Person David Matthew T · Officer Title Chief Financial Officer · Transaction Code A

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001213900-26-110340 · filed 2026-10-16 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Actinium Pharmaceuticals, Inc. (ATNM)." Disclosed 2026-10-16. https://desqlong.com/cards/0001213900-26-110340-1 (retrieved 2026-10-17).